H.R.1048 — DETERRENT Act
House Roll Call
H.R.1048
| Bill | H.R.1048 — DETERRENT Act |
|---|---|
| Vote question | On Passage |
| Vote type | Yea-and-Nay |
| Result | Passed |
| Totals | Yea 241 / Nay 169 / Present 0 / Not Voting 20 |
| Party | Yea | Nay | Present | Not Voting |
|---|---|---|---|---|
| R | 210 | 1 | 0 | 6 |
| D | 31 | 168 | 0 | 14 |
| I | 0 | 0 | 0 | 0 |
Research Brief
On Passage
Bill Analysis
The DETERRENT Act (HR 1048) aims to enhance the federal government’s capacity to combat the opioid crisis by establishing a comprehensive framework for prevention, treatment, and recovery services. The bill emphasizes the importance of data-driven approaches and interagency collaboration to address the multifaceted challenges posed by opioid misuse.
Key provisions of the DETERRENT Act include the establishment of a new grant program administered by the Department of Health and Human Services (HHS) to support state and local initiatives focused on opioid prevention and treatment. This program would provide funding for evidence-based practices, including medication-assisted treatment (MAT), harm reduction strategies, and community education efforts. The bill also mandates the development of a national strategy to improve access to treatment services, particularly in underserved areas.
Funding for the initiatives outlined in the DETERRENT Act is contingent upon appropriations, with an emphasis on leveraging existing federal resources to maximize impact. The bill encourages partnerships between federal agencies, including the Centers for Disease Control and Prevention (CDC), the Substance Abuse and Mental Health Services Administration (SAMHSA), and the Department of Justice (DOJ), to streamline efforts and share best practices.
Beneficiaries of the DETERRENT Act include individuals struggling with opioid use disorder, families affected by the crisis, and communities seeking to reduce the prevalence of opioid-related harm. The legislation also aims to regulate the distribution and prescription of opioids through enhanced monitoring and reporting requirements.
The DETERRENT Act was introduced in the House and has been referred to the Senate Committee on Health, Education, Labor, and Pensions for further consideration. Key timelines for implementation will depend on the appropriations process and subsequent legislative actions. Overall, the DETERRENT Act represents a strategic effort to bolster the federal response to the opioid epidemic through targeted funding and coordinated action.
Yea (241)
K
Ken Calvert
S
Scott Franklin
M
Mark Green
L
Lisa McClain
J
John Rutherford
D
David Schweikert
P
Pete Sessions
D
Debbie Wasserman Schultz
Nay (169)
G
Gerald Connolly
J
Jason Crow
L
Lloyd Doggett
J
John Mannion
E
Eric Swalwell
R
Rashida Tlaib
N
Nydia Velázquez
Not Voting (20)
J
John Garamendi
L
Lucy McBath
